从政府控制转向市场主导：药品价格形成机制的新转变  

From government control to market-oriented pricing :new transformation of the pharmaceutical pricing mechanism

作　　者：陈文[1] 

机构地区：[1]复旦大学公共卫生学院、健康风险预警治理协同创新中心,上海200032

出　　处：《中国卫生资源》2015年第4期237-238,共2页Chinese Health Resources

基　　金：国家社科基金重大项目(11&ZD176)

摘　　要：国家发展和改革委员会等7部委发布《推进药品价格改革的意见》提示了此次药品价格改革是逐步建立以市场为主导的药品价格形成机制,最大限度减少政府对药品价格的直接干预;机制转变是此次药品价格改革的内涵;政府作为市场参与主体,利用采购机制、医保支付机制和谈判机制实施市场干预,并通过医疗行为和价格行为监管实施综合管控,实现了药品价格形成机制从政府控制向市场主导的转变,而这一转变有赖于医疗保险与医疗服务相关政策的协同才能实现其最大效能。The Opinion on promoting pharmaceutical price reform issued by the National Development and Reform Commission and other six ministries points out the objective of gradually establishing a market-oriented pharmaceutical pricing mechanism to minimize direct government intervention on pharmaceutical prices. Mechanism transformation is the core of the pharmaceutical pricing reform. The governments,as market participants,will conduct the intervention through purchasing,payment and negotiation mechanisms and carry out comprehensive regulations through the regulations on medical and pricing behaviors to achieve the change from government control to market-oriented pricing. The effects of the change depend on the coordination of related policies of health insurance and health services.

关 键 词：药品价格改革 市场主导 药品价格形成机制 

分 类 号：R956[医药卫生—药学]